Medtronic Market-Released DF4 Lead Imaging

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01626768

Enrollment

Registered

2012-06-25

Start date

2012-06-30

Completion date

2013-05-31

Last updated

2013-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tachycardia

Brief summary

The Medtronic Market-Released DF4 Lead Imaging Study is a prospective, non-randomized study, multi-center clinical investigation. The purpose of this clinical investigation is to collect high quality medical images of the Medtronic Market-Released DF4 lead in the shoulder and heart. Images collected during the study will allow for lead design and testing processes better tailored to the implanted environment.

Interventions

None listed

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

19 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients greater than 18 years of age. * Patients able and willing to attend imaging session. * Patients able and willing to give informed consent. * Patients with an implanted device/lead(s) for a minimum of 3 months.

Exclusion criteria

* Subjects who require a legally authorized representative to obtain consent. * Subjects with

Design outcomes

Primary

Measure	Time frame
In vivo lead shape	Six Months

Countries

Saudi Arabia, United Kingdom

Outcome results